Securities code: 600222 securities abbreviation: Henan Taloph Pharmaceutical Stock Co.Ltd(600222) Announcement No.: 2022-008
Henan Taloph Pharmaceutical Stock Co.Ltd(600222)
Announcement on the renewal of accounting firm
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents. Important content tips:
Henan Taloph Pharmaceutical Stock Co.Ltd(600222) (hereinafter referred to as “the company”) plans to renew the appointment of Beijing Xinghua Certified Public Accountants (special general partnership) (hereinafter referred to as “Beijing Xinghua”) as the company’s 2021 financial report audit and internal control audit institution.
1、 Basic information of the accounting firm to be employed
(I) institutional information
1. Basic information
Beijing Xinghua certified public accountants Co., Ltd. (special general partnership), established in 1992, was transformed into a special general partnership with the approval of Beijing financial accounting license [2013] No. 0060 on November 22, 2013. Its registered address is room 2206, No. 18, Yumin Road, Xicheng District, Beijing.
The chief partner of Beijing Xinghua is Mr. Zhang Enjun. By the end of 2020, there were 102 partners and 585 certified public accountants, including 180 certified public accountants who signed the audit report of securities service business.
The total audited business income of Beijing Xinghua in 2020 was 743.3417 million yuan, including 555.715 million yuan from audit business and 63.1151 million yuan from securities business. Beijing Xinghua provides annual report audit services for 24 listed companies in 2020, with a total audit fee of 20.95 million yuan. The main industries involved include manufacturing, information transmission, software and information technology services, wholesale and retail, transportation, real estate, leasing and commercial services, scientific research and technical services, communication and cultural industries. Among the audit clients, there are 4 listed companies in the same industry as the company.
Securities code: 600222 securities abbreviation: Henan Taloph Pharmaceutical Stock Co.Ltd(600222) Announcement No.: 2022-008
2. Investor protection ability
Beijing Xinghua has purchased occupational insurance, which complies with relevant regulations and covers the civil liability for providing audit services according to law. The liability limit for each accident is 100 million yuan and the annual cumulative compensation limit is 200 million yuan.
3. Integrity record
In the past three years (from 2018 to 2020), Beijing Xinghua has received (received) administrative punishment 4 times and supervision and management measures 8 times for practicing behavior, and has not received (received) criminal punishment and industry self-discipline punishment. 17 employees have been subject to criminal punishment once, administrative punishment 4 times, supervision and management measures 6 times and self-discipline supervision measures 0 times in recent three years.
(II) project member information
1. Basic information
Project partner: Tan Zhe, who became a certified public accountant in 2016, began to audit listed companies in 2011, began to practice in Beijing Xinghua in 2016, and began to provide audit services for the company in 2019; Audit reports of five listed companies have been signed in the past three years.
Signature certified public accountant: Hou Jingyi, who became a certified public accountant in 2019, began to engage in the audit of Listed Companies in 2017, began to practice in Beijing Xinghua in 2021, and has not signed the audit report of Listed Companies in recent three years.
Reviewer of project quality control: Chen Peng, who became a Chinese certified public accountant in 1995, began to audit listed companies in 1997 and began to practice in Beijing Xinghua in 1995. More than 10 listed companies have been reviewed in recent three years.
2. Integrity record
The above-mentioned personnel of Beijing Xinghua have not been subject to criminal punishment, administrative punishment, supervision and management measures, self-discipline supervision measures and disciplinary sanctions for their practice in recent three years.
(III) independence
The proposed partners of Beijing Xinghua and the above projects, signed certified public accountants and
Securities code: 600222 securities abbreviation: Henan Taloph Pharmaceutical Stock Co.Ltd(600222) Announcement No.: 2022-008
There is no situation that may affect the independence of the project quality control reviewer.
(IV) audit fees
The audit cost of the company’s financial report in 2021 is 1.1 million yuan, and the audit cost of internal control is 380000 Yuan, which is the same as that in 2020. The current audit fee is based on the time cost spent by Beijing Xinghua employees at all levels in the audit, taking into account the responsibilities of professional services and other factors, and determined through consultation with the accounting firm in accordance with the market fair and reasonable pricing principle.
2、 Procedures to be performed by the accounting firm to be renewed
(I) opinions of the audit committee of the board of directors
The audit committee of the board of directors of the company believes that Beijing Xinghua has due professional competence, investor protection ability, independence and good integrity, and can meet the requirements of the company’s annual financial report audit and internal control audit, so as to ensure the stability and continuity of the company’s audit work, Agree to reappoint Beijing Xinghua as the company’s 2021 financial report audit and internal control audit institution, and agree to submit the proposal on reappointment of accounting firm to the 22nd Meeting of the eighth board of directors for deliberation.
(II) prior approval and independent opinions of independent directors
Prior approval opinions of independent directors: Beijing Xinghua is qualified to engage in Securities and futures related businesses, has many years of experience and ability to provide audit services for the company, adheres to the audit principles of independence, objectivity and impartiality in the process of practice, strictly abides by the independent audit standards for Chinese Certified Public Accountants, is diligent and responsible, and carries out audit work seriously and solidly, The audit work of the company has been well completed. We agree to submit the proposal to the 22nd Meeting of the 8th board of directors of the company for deliberation.
Independent opinions of independent directors: Beijing Xinghua is the company’s external auditor, and the employment procedures comply with the provisions of relevant laws and regulations. There is no situation that damages the interests of the company and shareholders, especially small and medium-sized investors. Agree to renew the employment of Beijing Xinghua on the company’s 2021 financial report and
Securities code: 600222 securities abbreviation: Henan Taloph Pharmaceutical Stock Co.Ltd(600222) Announcement No.: 2022-008
Audit the effectiveness of the control department and issue the audit report.
(III) deliberation and voting of the board of directors
The company held the 22nd Meeting of the 8th board of directors on February 9, 2022. The proposal on renewing the appointment of accounting firm was deliberated and approved by 8 votes for, 0 against and 0 abstention, and the company agreed to renew the appointment of Beijing Xinghua as the company’s 2021 financial report audit and internal control audit institution.
(IV) the renewal of the accounting firm needs to be submitted to the general meeting of shareholders of the company for deliberation and effective from the date of deliberation and approval by the general meeting of shareholders of the company.
It is hereby announced.
Henan Taloph Pharmaceutical Stock Co.Ltd(600222) board of directors February 10, 2022
